21Shares has filed an amended registration statement with the U.S. Securities and Exchange Commission to list a spot Injective exchange-traded fund on Nasdaq, updating a product that would hold the INJ token and trade under the proposed ticker TINJ. The S-1/A, filed with the SEC on September 18, is the first amendment to a registration the asset manager originally submitted in October 2025 and adds fresh detail to a widening race to bring altcoin ETFs to U.S. markets.